Catherine Couturier

Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

Mohamad Mohty, Evangelos Terpos, María‐Victoria Mateos et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 89 citations · Full text

Medicine, Hematology, Pharmacoeconomics +14

Distribution and antibacterial susceptibility of macrolide resistance genotypes in Streptococcus pneumoniae: PROTEKT Year 5 (2003–2004)

David J. Farrell, Catherine Couturier, Waleria Hryniewicz · International Journal of Antimicrobial Agents · 2008 · 62 citations

Life Sciences, Infectious Diseases, Microbiology +17

Phase II study of bortezomib-dexamethasone alone or with added cyclophosphamide or lenalidomide for sub-optimal response as second-line treatment for patients with multiple myeloma

Meletios Α. Dimopoulos, Meral Beksaç, Lotfi Benboubker et al. · Haematologica · 2013 · 39 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myeloma

Meletios Α. Dimopoulos, Robert Z. Orlowski, T. Facon et al. · Haematologica · 2014 · 31 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Activities of a New Oral Streptogramin, XRP 2868, Compared to Those of Other Agents against <i>Streptococcus pneumoniae</i> and <i>Haemophilus</i> Species

Glenn A. Pankuch, Linda M. Kelly, Gengrong Lin et al. · Antimicrobial Agents and Chemotherapy · 2003 · 28 citations · Full text

Medicine, Infectious Diseases, Pharmacology +13